Clinical Trial Update: Comparative Effectiveness of Empagliflozin in the US

View source ↗

Summary

This document provides a status update on a US comparative effectiveness trial of empagliflozin for adults with Type 2 diabetes, indicating the study is active …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Status: ACTIVE_NOT_RECRUITING